COVID-19 Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FT8G
|
|||
| Drug Name |
PX-12
|
|||
| Synonyms |
PX12; PX 12; IV-2
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) | Investigative | [1] | |
| Other Indication | Pancreatic cancer | Phase 2 | [2] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Company |
Biomira
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H12N2S2
|
|||
| Canonical SMILES |
CCC(C)SSC1=NC=CN1
|
|||
| InChI |
1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9)
|
|||
| InChIKey |
BPBPYQWMFCTCNG-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 141400-58-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9374284, 15219811, 30422463, 57399846, 79245557, 103106749, 103564705, 113468605, 117402020, 123121574, 126460084, 135142363, 140114675, 162249061, 162310065, 162790932, 164154946, 164210775, 170364272, 174006855, 175427007, 177748841, 204361145, 210274949, 210280587, 215774935, 223392225, 223435396, 227058245, 243264143, 252156900, 252161718, 252475622
|
|||
| ChEBI ID |
CHEBI:94291
|
|||
| Target | Top | |||
|---|---|---|---|---|
| Target(s) | COVID-19 papain-like proteinase (PL-PRO) | Target Info | Inhibitor | [1] |
| PX-12 inhibits SARS-CoV-2 Mpro through a combination of structure-based screening and FRET-based enzymatic assay (IC50 = 21.39 microM). | ||||
| References | Top | |||
|---|---|---|---|---|
| 1 | Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020 Apr 9. | |||
| 2 | A Randomized Phase II Study of PX-12, an Inhibitor of Thioredoxin in Patients With Advanced Cancer of the Pancreas Following Progression After a Gemcitabine-Containing Combination. Cancer Chemother Pharmacol. 2011 Mar;67(3):503-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.